Hester Biosciences to receive Rs 60 crore grant from BIRAC for COVID vaccine manufacturing
New Delhi: Hester Biosciences on Thursday said it will receive a Rs 60-crore grant from Biotechnology Industry Research Assistance Council (BIRAC) to support COVID-19 vaccine manufacturing.
''The company's board has approved execution of grant-in-aid letter agreement for a grant of Rs 60 crore (in phased manner) to the drug maker by BIRAC under Mission COVID Suraksha,'' Hester Biosciences said in a regulatory filing.
Read also: Hester India to acquire 50 percent stake in Thrishool Exim for Rs 16 crore
Last year, a Memorandum of Understanding was inked between Bharat Biotech and Gujarat COVID Vaccine Consortium (GCVC) for the production of Covaxin.
GCVC comprises Gujarat Biotechnology Research Centre, Hester Biosciences and OmniBRx Biotechnologies.
Read also: Hester Biosciences Limited ventures into Pet Care Industry
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd